Healthcare Business

Can Marijuana Help Alzheimer's Patients?

Douglas A. McIntyre

This year marks a watershed in state legalization of marijuana, triggered by a change in social norms, the taxation yield promise, and the fact that, in many states, marijuana is already approved for medical use. A new study published by the US National Library of Medicine, National Institutes of Health reports that marijuana may help with some symptoms of Alzheimer’s

In a paper entitled “Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia”:

Vascular dementia is the highly devastating neurodegenerative disorder after Alzheimer’s disease (AD) and mainly found in aged people but the effectual therapeutic target is still not there. Chronic cerebral hypoperfusion (CCH) has been broadly found in vascular dementia (VaD) patients. CCH is thought to link with neurodegenerative disorders and their subsequent cognitive deteriorate on. This study has been framed to examine the role of a selective agonist of cannabinoid receptor type 2(CB2); 1-phenylisatin in CCH induced VaD. Permanent bilateral common carotid arteries ligation or two vessels occlusion (2VO) technique was used to induce CCH in rats. 2VO animals have shown significant impairment in learning-memory (Morris water maze) and in executive functioning (Attentional set-shifting test). These animals have shown a considerable reduction in brain oxidative stress (thiobarbituric reactive acid substance-TBARS; glutathione-GSH; catalase-CAT and superoxide dismutase-SOD), mitochondrial dysfunction (complexes I, II, IV) with a significant enhancement in cholinergic activity- AChE and brain infarct size2,3,5-triphenylterazolium chloride staining (TTC staining). Animals treated with 2VO have also demonstrated a considerable augmentation in brain edema (water content). Oral administration of 1-phenylisatin has significantly recuperated 2VO induced impairment in learning-memory, an increase in TBARS, GSH, CAT, SOD, mitochondrial activity with a significant reduction in AChE activity and brain damage. Administration of 1-phenylisatin has also reported recovering brain edema in these animals. These results indicate that 2VO induced CCH in rats, which was attenuated with the treatment of 1-phenylisatin. Hence, it may be suggested that modulation of cannabinoid receptor may provide benefits in CCH as cognitive impairment and VaD. Therefore, selective agonists of CB2 receptors may be a potential research target for the alleviation of VaD.

Like most potential treatments, the article abstract indicates that hard results for an effective marijuana solution are a ways off, if they ever materialize.

The possibility of marijuana as a treatment for Alzheimer’s is not new.

According to CNN,

Could medical marijuana treat Alzheimer’s patients? One recent study found THC, the psychoactive ingredient in cannabis, stimulates the removal of toxic plaque in the brain, a common feature of the disease. Furthermore, the researchers discovered it blocks inflammation, which damages neurons in the brain.
“It is reasonable to conclude that there is a therapeutic potential of cannabinoids for the treatment of Alzheimer’s disease,” wrote David Schubert, senior researcher and a professor at Salk Institute for Biological Studies.

CNN reported on several other studies and a substantial amount of skepticism on the parts of some in the medical community